Pure and Applied Chemistry, 2009, Volume 81, No. 6, pp. 1085-1091, References

Pure Appl. Chem., 2009, Vol. 81, No. 6, pp. 1085-1091

http://dx.doi.org/10.1351/PAC-CON-08-07-12

Published online 2009-05-05

Structure-based synthesis: From natural products to drug prototypes

Stephen Hanessian

Department of Chemistry, Université de Montréal, C. P. 6128, Succ. Centre-ville, Montréal, QC, H3C 3J7, Canada

References

1. (a). D. D. Baker, M. Chu, U. Oza, V. Rajgarhia. Nat. Prod. Rep. 24, 1225 (2007); (http://dx.doi.org/10.1039/b602241n)
1. (b). M. S. Butler. Nat. Prod. Rep. 22, 162 (2005); (http://dx.doi.org/10.1039/b402985m)
1. (c). V. P. Gullo (Ed.). The Discovery of Natural Products with Therapeutic Potential, Butterworth-Heinemann, Boston (1994).
2. (a). K. C. Nicolaou, T. Montagnon. Molecules that Changed the World, Wiley-VCH, Weinheim (2008);
2. (b). E. J. Corey, B. Czako, L. Kurti. Molecules and Medicine, John Wiley, New York (2007);
2. (c). K. C. Nicolaou, E. J. Sorensen. Classics in Total Synthesis II, Wiley-VCH, Weinheim (2003).
3. (a). W. Cabri, R. DiFabio. From Bench to MarketThe Evolution of Chemical Synthesis, Oxford University Press, Oxford (2000);
3. (b). K. G. Gadamasetti (Ed.). Process Chemistry in the Pharmaceutical Industry, Dekker, New York (1999);
3. (c). : M. F. Lipton, A. G. M. Barrett (Guest Eds.). Chem. Rev. 106, 2581 (2006).
4. (a). S. B. Shuker, P. J. Hajduk, R. P. Meadows, S. W. Fesik. Science 274, 1531 (1996); (http://dx.doi.org/10.1126/science.274.5292.1531)
4. (b). J. Fejzo, C. A. Lepre, J. W. Peng, G. W. Bemis, Ajay, M. A. Murcko, J. M. Moore. Chem. Biol. 6, 755 (1999);
4. (c). M. Pellechia, D. S. Sem, K. Wuthrich. Nat. Rev. Drug Discov. 1, 211 (2002); (http://dx.doi.org/10.1038/nrd748)
4. (d). V. L. Nienaber, P. L. Richardson, V. Klighofer, J. J. Bouska, V. L. Giranda, J. Greer. Nat. Biotechnol. 18, 1105 (2000); (http://dx.doi.org/10.1038/80319)
4. (e). A. Sharff, H. Jhoti. Curr. Opin. Chem. Biol. 7, 340 (2003); (http://dx.doi.org/10.1016/S1367-5931(03)00062-0)
4. (f). L. Blundell, H. Jhoti, C. Abell. Nat. Rev. Drug Discov. 1, 45 (2002). (http://dx.doi.org/10.1038/nrd706)
5. M. Gordaliza. Clin. Transl. Oncol. 9, 767 (2007). (http://dx.doi.org/10.1007/s12094-007-0138-9)
6. (a). K. Ersmark, J. R. Del Valle, S. Hanessian. Angew. Chem., Int. Ed. 47, 1202 (2008); (http://dx.doi.org/10.1002/anie.200605219)
6. (b). J. W. Blunt, B. R. Copp, W.-P. Hu, M. H. G. Munro, P. T. Northcote, M. R. Prinsep. Nat. Prod. Rep. 24, 31 (2007); (http://dx.doi.org/10.1039/b603047p)
6. (c). A. M. Burja, B. Banaigs, E. Abou-Mansour, J. G. Burgess, P. C. Wright. Tetrahedron 57, 9347 (2001); (http://dx.doi.org/10.1016/S0040-4020(01)00931-0)
6. (d). W. J. Gerwick, L. T. Tan, N. Sitachitta. In Alkaloids: Chemistry and Biology, Vol. 57, p. 75, G. A. Cordell (Ed.), Academic Press, San Diego (2001);
6. (e). H. Luesch, G. G. Harrigan, G. Goetz, F. D. Horgen. Curr. Med. Chem. 9, 1791 (2002);
6. (f). M. Namikoshi, K. L. Rinehart. J. Int. Microbiol. 17, 373 (1996); (http://dx.doi.org/10.1007/BF01574768)
6. (g). R. Lukkainen, K. Sivonen, M. Manikoshi, M. Fardig, K. L. Rinehart, S. I. Nimela. Appl. Environ. Microbiol. 59, 2204 (1993).
7. (a). T. Ohshima, V. Gnanadesikan, T. Shibuguchi, Y. Fukuta, T. Nemoto, M. Shibasaki. J. Am. Chem. Soc. 125, 11206 (2003); (http://dx.doi.org/10.1021/ja037290e)
7. (b). N. Valls, M. Lopez-Canet, M. Vallribera, J. Bonjoch. Chem.Eur. J. 7, 3446 (2001); (http://dx.doi.org/10.1002/1521-3765(20010817)7:16<3446::AID-CHEM3446>3.0.CO;2-0)
7. (c). J.-L. Methot, P. Wipf. Org. Lett. 2, 4213 (2000); (http://dx.doi.org/10.1021/ol006759x)
7. (d). N. Valls, M. Lopez-Canet, M. Vallribera, J. Bonjoch. J. Am. Chem. Soc. 122, 11248 (2000); (http://dx.doi.org/10.1021/ja002341i)
7. (e). J. L. Rios Teiner, M. Murakami, A. Tulinsky. J. Am. Chem. Soc. 120, 597 (1998). (http://dx.doi.org/10.1021/ja973038t)
8. (a). E. W. Davie, J. D. Kulman. Semin. Thromb. Hemostasis 32, 3 (2006); (http://dx.doi.org/10.1055/s-2006-939550)
8. (b). B. Dahlback. J. Int. Med. Res. 257, 209 (2005); (http://dx.doi.org/10.1111/j.1365-2796.2004.01444.x)
8. (c). J. D. Kulman, E. W. Davie. Encycl. Biol. Chem. 3, 457 (2004);
8. (d). The World Health Organization (WHO) Cardiovascular Disease (CVD); Global Strategy on Diet, Physical Activity and Health, WHO (2003);
8. (e). E. W. Davie. J. Biol. Chem. 278, 50819 (2003); (http://dx.doi.org/10.1074/jbc.X300009200)
8. (f). R. W. Colman, A. W. Clowes, J. N. George, J. L. Hirsch, J. V. Marder. In Overview of Homeostasis, 4th ed., R. W. Colman, J. L. Hirsh, J. V. Marder, A. W. Clowes, J. N. George (Eds.), p. 3, Lippincott Williams & Wilkins, Philadelphia (2001);
8. (g). J. J. Sidelmann, J. Gram, J. Jespersen, C. Kluft. Semin. Thromb. Hemostasis 26, 605 (2000). (http://dx.doi.org/10.1055/s-2000-13216)
9. (a). S. Hanessian, J. R. Del Valle, Y. Xue, N. Blomberg. J. Am. Chem. Soc. 128, 10491 (2006); (http://dx.doi.org/10.1021/ja0625834)
9. (b). G. H. Goetz, G. G. Harrigan, J. J. Likos, T. D. Kasten. WO 03/051831.
10. (a). S. Hanessian, R. Margarita, A. Hale, S. Johnstone, M. Tremblay, L. Parlanti. J. Am. Chem. Soc. 124, 13342 (2002); (http://dx.doi.org/10.1021/ja0208153)
10. (b). S. Hanessian, R. Margarita, A. Hall, S. Johnstone, M. Tremblay, L. Parlanti. Pure Appl. Chem. 75, 209 (2003); (http://dx.doi.org/10.1351/pac200375020209)
10. (c). A. R. Caroll, G. Pierens, G. Fecher, G. P. de Almeida Leone, M. Simpson, J. N. Hooper, S.-L. Bostrom, D. Musil, R. J. Quinn. J. Am. Chem. Soc. 124, 13340 (2002); (http://dx.doi.org/10.1021/ja020814a)
10. (d). A. R. Carroll, M. S. Buchanan, A. Edser, E. Hyde, M. Simpson, R. J. Quinn. J. Nat. Prod. 67, 1291 (2004). (http://dx.doi.org/10.1021/np049968p)
11. (a). S. Hanessian, M. Tremblay, J. F. W. Petersen. J. Am. Chem. Soc. 126, 6064 (2004); (http://dx.doi.org/10.1021/ja030669g)
11. (b). R. Engh, S. Konetschny-Rapp, H.-W. Krell, U. Martin. WO 96/11941;
11. (c). R. Engh, S. Konetschny-Rapp, H.-W. Krell, U. Martin, C. Tsaklakidis. WO 97/21725.
12. W. Bode, D. Turk, A. Karshikov. Protein Sci. 1, 426 (1992).
13. S. Hanessian, E. Balaux, D. Musil, L.-L. Olsson, I. Nilsson. Bioorg. Med. Chem. Lett. 10, 243 (2000). (http://dx.doi.org/10.1016/S0960-894X(99)00669-1)
14. (a). S. Hanessian, E. Therrien, K. Granberg, I. Nilsson. Bioorg. Med. Chem. Lett. 12, 2907 (2002); (http://dx.doi.org/10.1016/S0960-894X(02)00612-1)
14. (b). S. Hanessian, H. Sailes, A. Munro, E. Therrien. J. Org. Chem. 68, 7219 (2003). (http://dx.doi.org/10.1021/jo030145z)
15. S. Hanessian, H. Sailes, E. Therrien. Tetrahedron 59, 7047 (2003). (http://dx.doi.org/10.1016/S0040-4020(03)00919-0)
16. (a). Z. Liu, J. D. Ranier. Org. Lett. 8, 459 (2006); (http://dx.doi.org/10.1021/ol052741g)
16. (b). X. Nie, G. Wang. J. Org. Chem. 70, 8687 (2005); (http://dx.doi.org/10.1021/jo0507901)
16. (c). Y. Fukuta, T. Ohshima, V. Gnanadesikan, T. Shibuguchi, T. Nemoto, T. Kisugi, T. Okino, M. Shibasaki. Proc. Natl. Acad. Sci. USA 101, 5433 (2004); (http://dx.doi.org/10.1073/pnas.0307154101)
16. (d). N. Toyooka, M. Okumura, T. Himiyama, A. Nakazawa, H. Nemoto. Heterocycles 59, 75 (2003); (http://dx.doi.org/10.3987/COM-02-S24)
16. (e). N. Toyooka, M. Okumura, T. Himiyama, A. Nakazawa, H. Nemoto. Synlett 55 (2003);
16. (f). N. Valls, M. Vallribera, M. Font-Bardia, X. Solans, J. Bonjoch. Tetrahedron: Asymmetry 14, 1241 (2003); (http://dx.doi.org/10.1016/S0957-4166(03)00170-8)
16. (g). G. Radau, J. Sturzebecher. Pharmazie 57, 11 (2002);
16. (h). G. Radeau, D. Rauh. Bioorg. Med. Chem. Lett. 10, 779 (2000); (http://dx.doi.org/10.1016/S0960-894X(00)00101-3)
16. (i). J. Bonjoch, J. Catena, E. Isabal, M. Lopez-Canet, N. Valls. Tetrahedron: Asymmetry 7, 1999 (1996); (http://dx.doi.org/10.1016/0957-4166(96)00225-X)
16. (j). P. Wipf, Y. Kim. Tetrahedron Lett. 33, 5477 (1992); (http://dx.doi.org/10.1016/S0040-4039(00)61121-8)
16. (k). T. Doi, Y. Hoshina, H. Mogi, Y. Yamada, T. Takahashi. J. Comb. Chem. 8, 571 (2006). (http://dx.doi.org/10.1021/cc0600270)
17. S. Hanessian, S. Guillemette, K. Ersmark. Chimia 61, 361 (2007). (http://dx.doi.org/10.2533/chimia.2007.361)
18. S. Hanessian, K. Ersmark, J. Wang, J. R. Del Valle, N. Blomberg, Y. Xue, O. Fjellstrom. Bioorg. Med. Chem. Lett. 17, 3480 (2007). (http://dx.doi.org/10.1016/j.bmcl.2007.03.075)
19. S. Hanessian, E. Therrien, W. A. L. van Otterlo, M. Bayrakdarian, I. Nilsson, O. Fjellstrom, Y. Xue. Bioorg. Med. Chem. Lett. 16, 1032 (2006). (http://dx.doi.org/10.1016/j.bmcl.2005.10.082)
20. S. Hanessian, D. Simard, M. Bayrakdarian, E. Therrien, I. Nilsson, O. Fjellstrom. Bioorg. Med. Chem. Lett. 18, 1972 (2008). (http://dx.doi.org/10.1016/j.bmcl.2008.01.122)
21. K. Berggren, O. Davidsson, O. Fjellstrom, D. Gustafsson, S. Hanessian, T. Inghardt, M. Nagard, I. Nilsson, E. Therrien, W. A. L. Van Otterlo. WO 2005/058826.
22. S. Hanessian. ChemMedChem 1, 1300 (2006). (http://dx.doi.org/10.1002/cmdc.200600203)

Pure and Applied Chemistry

Navigation

PAC Archives

RSS Feeds

Highlights

Structure-based synthesis: From natural products to drug prototypes

References

Pure and Applied Chemistry

Navigation

Search PAC

PAC Archives

RSS Feeds

Highlights

Structure-based synthesis: From natural products to drug prototypes

References